Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Common Equity (2016 - 2025)

Rockwell Medical's Common Equity history spans 16 years, with the latest figure at $37.0 million for Q4 2025.

  • For Q4 2025, Common Equity rose 13.49% year-over-year to $37.0 million; the TTM value through Dec 2025 reached $37.0 million, up 13.49%, while the annual FY2025 figure was $37.0 million, 13.49% up from the prior year.
  • Common Equity reached $37.0 million in Q4 2025 per RMTI's latest filing, roughly flat from $37.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $37.0 million in Q3 2025 to a low of -$4.8 million in Q1 2022.
  • Average Common Equity over 5 years is $20.5 million, with a median of $21.0 million recorded in 2023.
  • The largest YoY upside for Common Equity was 456.45% in 2022 against a maximum downside of 118.36% in 2022.
  • A 5-year view of Common Equity shows it stood at $2.5 million in 2021, then skyrocketed by 456.45% to $14.1 million in 2022, then skyrocketed by 50.94% to $21.3 million in 2023, then soared by 53.05% to $32.6 million in 2024, then increased by 13.49% to $37.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Common Equity are $37.0 million (Q4 2025), $37.0 million (Q3 2025), and $30.4 million (Q2 2025).